TP53 and pancreatic neoplasm: Here we took advantage of a mouse pancreatic cancer model containing a unique reporter system to trace genome evolution after sporadic p53 inactivation during a previously inaccessible phase of cancer evolution initiated by p53 loss of function—at the benign-to-malignant transition.